Microparticles as mediators of cellular cross-talk in inflammatory diseaseDISTLER, Jörg H. W; HUBER, Lars C; GAY, Steffen et al.Autoimmunity (Print). 2006, Vol 39, Num 8, pp 683-690, issn 0891-6934, 8 p.Article

Granulocyteaphaeresis in steroid-dependent inflammatory bowel disease: a prospective, open, pilot studyDOMENECH, E; HINOJOSA, J; ESTEVE-COMAS, M et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 11-12, pp 1347-1352, issn 0269-2813, 6 p.Article

Aminosalicylates in inflammatory bowel diseaseHANAUER, S. B.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 60-65, issn 0953-0673, 6 p.Article

Helminths as therapeutic agents for inflammatory bowel diseaseHUNTER, M. M; MCKAY, D. M.Alimentary pharmacology & therapeutics. 2004, Vol 19, Num 2, pp 167-177, issn 0269-2813, 11 p.Article

Advances in inflammatory bowel disease : Diagnosis and therapyTORRES, M. I; RIOS, A.Recent research developments in life science (Vol. 2 (2004)). Recent research developments in life science. 2004, pp 195-215, isbn 81-7736-216-X, 21 p.Book Chapter

Le pentasa : traitement d'attaque et d'entretien des maladies inflammatoires intestinales = The PENTASA: Attack and maintenance treatment in inflammatory bowel diseaseCHEVREL, B.Médecine et chirurgie digestives (Paris). 1989, Vol 18, Num 7, pp 431-436, issn 0047-6412, 6 p.Article

Granulomatous aspecific orchitis: report of a case and review of literatureSALTUTTI, C; TRIPPITELLI, A; DI CELLO, V et al.Acta urologica belgica. 1984, Vol 52, pp 605-609, issn 0001-7183Article

Inflammatory bowel diseaseMOLL, J. M. H.Clinics in rheumatic diseases. 1985, Vol 11, Num 1, pp 87-111, issn 0307-742XArticle

A polymeric drug for treatment of inflammatory bowel diseaseBROWN, J. P; MCGARRAUGH, G. V; PARKINSON, T. M et al.Journal of medicinal chemistry (Print). 1983, Vol 26, Num 9, pp 1300-1307, issn 0022-2623Article

Patients' fears and unmet needs in inflammatory bowel diseaseIRVINE, E. J.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 54-59, issn 0953-0673, 6 p.Article

Leucocyte scanning: preparation and labelling of leucocytes with ¹¹¹-indium oxine and its clinical applicationLAUE, A; HEINKEN, U; SCHULZ-HEINKEN, D et al.European journal of nuclear medicine. 1984, Vol 9, Num 1, pp 17-22, issn 0340-6997Article

Treatment of Crohn's disease with peroral 5-aminosalicyclic acidRASMUSSEN, S. N; BINDER, V; MAIER, K et al.Gastroenterology (New York, NY. 1943). 1983, Vol 85, Num 6, pp 1350-1353, issn 0016-5085Article

Caveolae: A regulatory platform for nutritional modulation of inflammatory diseasesLAYNE, Joseph; MAJKOVA, Zuzana; SMART, Eric J et al.Journal of nutritional biochemistry. 2011, Vol 22, Num 9, pp 807-811, issn 0955-2863, 5 p.Article

Altered bone metabolism in inflammatory disease : role for nutritionCASHMAN, Kevin D.Proceedings of the Nutrition Society. 2008, Vol 67, Num 2, pp 196-205, issn 0029-6651, 10 p.Conference Paper

Triptolide in the treatment of psoriasis and other immune-mediated inflammatory diseasesRUI HAN; ROSTAMI-YAZDI, Martin; GERDES, Sascha et al.British journal of clinical pharmacology. 2012, Vol 74, Num 3, pp 424-436, issn 0306-5251, 13 p.Article

The genetics of chronic inflammatory diseasesHEAP, Graham A; VAN HEEL, David A.Human molecular genetics (Print). 2009, Vol 18, issn 0964-6906, R101-R106, NS1Article

Nutritional concerns in pediatric inflammatory bowel disease patients : Nutrition and inflammatory bowel diseaseKAPPELMAN, Michael D; BOUSVAROS, Athos.Molecular nutrition & food research (Print). 2008, Vol 52, Num 8, pp 867-874, issn 1613-4125, 8 p.Article

A prospective assessment of cytomegalovirus infection in active inflammatory bowel diseaseDE SAUSSURE, P; LAVERGNE-SLOVE, A; MAZERON, M.-C et al.Alimentary pharmacology & therapeutics. 2004, Vol 20, Num 11-12, pp 1323-1327, issn 0269-2813, 5 p.Article

Impact of inflammatory disease on the nerve microenvironmentPOWELL, Henry C; MYERS, Robert R.Journal of the neurological sciences. 2004, Vol 220, Num 1-2, pp 131-132, issn 0022-510X, 2 p.Conference Paper

Gut flora and inflammatory bowel diseaseMARTEAU, P; LEPAGE, P; MANGIN, I et al.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 18-23, issn 0953-0673, 6 p.Article

Antibiotics and probiotics in inflammatory bowel diseaseKRUIS, W.Alimentary pharmacology & therapeutics. Supplement. 2004, Vol 20, Num 4, pp 75-78, issn 0953-0673, 4 p.Article

Spleen size in patients with inflammatory bowel disease: does it have any clinical significance?PEREIRA, J. L. R; HUGHES, L. E; YOUNG, H. L et al.Diseases of the colon & rectum. 1987, Vol 30, Num 6, pp 403-409, issn 0012-3706Article

Nutritional aspects of inflammatory bowel diseaseROSENBERG, I. H; BENGOA, J. M; SITRIN, M. D et al.Annual review of nutrition. 1985, Vol 5, pp 463-484, issn 0199-9885Article

Prostaglandins and ulcerative colitisRAMPTON, D. S; HAWKEY, C. J.Gut. 1984, Vol 25, Num 12, pp 1399-1413, issn 0017-5749Article

Circulating galectin-3 in infections and non-infectious inflammatory diseasesTEN OEVER, J; GIAMARELLOS-BOURBOULIS, E. J; NETEA, M. G et al.European journal of clinical microbiology & infectious diseases (Print). 2013, Vol 32, Num 12, pp 1605-1610, issn 0934-9723, 6 p.Article